Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02660645 · ClinicalTrials.gov registry record
Blue Light Cystoscopy With Cysview® Registry
A clinical trial of Bladder Cancer, sponsored by Photocure.
- Recruiting
- Registry status
- 4,400
- Enrollment target
- 20
- Study locations
NCT02660645: Recruiting study of Bladder Cancer, sponsored by Photocure.
NCT02660645 is a study of Bladder Cancer that is actively recruiting participants, run by Photocure. The registered enrollment target is 4,400 participants, below the 12,729-participant average among 175 other Bladder Cancer trials with a reported enrollment target (65% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02660645, a study of Bladder Cancer, is actively recruiting participants, sponsored by Photocure.
- RECRUITING
- Registry status
- 4,400 participants
- Enrollment target
- 20
- Study locations
Study Summary
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Primary Outcome
Rate of detection of bladder malignancies with Blue Light Cystoscopy with Cysview versus white light cystoscopy alone.
Conditions Studied
Interventions
- DEVICE Karl Storz D-Light C Photodynamic Diagnostic (PDD) system
- DRUG Hexaminolevulinate hydrochloride (HCL)
Study Locations (20)
California
- USC/Norris Comprehensive Cancer Center - Los Angeles
- University of California Los Angeles - Los Angeles
- VA Palo Alto Health Care System - Palo Alto
- University of California, San Francisco - San Francisco
Illinois
- Northwestern University - Chicago
- Northshore University Health System - Evanston
New York
- NYU Langone's Perlmutter Cancer Center - New York
- Stony Brook Urology - Stony Brook
Ohio
- Ohio State University Wexner Medical Center - Columbus
- Ohio State University - Columbus
Alabama
- The University of Alabama at Birmingham - Birmingham
Arizona
- Mayo Clinic - Phoenix
District of Columbia
- Sibley Memorial Hospital - Washington D.C.
Georgia
- Emory University School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,400 participants |
| Start Date | 2014-04 |
| Est. Completion | 2028-12 |
What NCT02660645 shows while recruiting
NCT02660645 is an observational study that tracks outcomes without assigning an intervention. Its 4,400 participants enrollment target places it among the larger protocols in the corpus, below the 12,729-participant average among 175 other Bladder Cancer trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 2 interventions - of which Karl Storz D-Light C Photodynamic Diagnostic (PDD) system is the first listed.
NCT02660645 names 20 study sites across 14 states, led by California, Illinois, New York.
Frequently Asked Questions
What is clinical trial NCT02660645 about?
NCT02660645 is a clinical study titled "Blue Light Cystoscopy With Cysview® Registry". Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
What is the current status of trial NCT02660645?
This trial is currently recruiting. The enrollment target is 4,400 participants. The study started on 2014-04. Estimated completion is 2028-12.
What conditions does trial NCT02660645 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT02660645?
The interventions under investigation include: Karl Storz D-Light C Photodynamic Diagnostic (PDD) system (DEVICE), Hexaminolevulinate hydrochloride (HCL) (DRUG).
Who is sponsoring clinical trial NCT02660645?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02660645 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02660645's enrollment target sits among peer trials
4,400 8th of 175 higher than 168 of 175 other Bladder Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bladder Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
RECRUITING · Phase 1
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
RECRUITING · Phase 1
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07044297 · 4,390 participants · Phase 3
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
- NCT05910567 · 4,346 participants · NA
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia